Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Index- P/E- EPS (ttm)-0.03 Insider Own17.57% Shs Outstand9.48M Perf Week0.45%
Market Cap84.19M Forward P/E14.78 EPS next Y0.60 Insider Trans0.00% Shs Float7.82M Perf Month-1.00%
Enterprise Value95.07M PEG- EPS next Q0.02 Inst Own33.42% Short Float0.32% Perf Quarter9.37%
Income-0.31M P/S0.98 EPS this Y26100.00% Inst Trans0.27% Short Ratio0.97 Perf Half Y20.52%
Sales86.20M P/B1.16 EPS next Y130.77% ROA-0.31% Short Interest0.02M Perf YTD13.28%
Book/sh7.63 P/C13.18 EPS next 5Y- ROE-0.43% 52W High12.53 -29.21% Perf Year-20.16%
Cash/sh0.67 P/FCF- EPS past 3/5Y-86.00% - ROIC-0.42% 52W Low6.75 31.41% Perf 3Y-31.03%
Dividend Est.- EV/EBITDA- Sales past 3/5Y4.34% 12.07% Gross Margin37.00% Volatility3.22% 4.16% Perf 5Y-40.87%
Dividend TTM0.04 (0.45%) EV/Sales1.10 EPS Y/Y TTM-106.01% Oper. Margin-6.99% ATR (14)0.38 Perf 10Y66.41%
Dividend Ex-DateJan 28, 2026 Quick Ratio1.13 Sales Y/Y TTM-0.01% Profit Margin-0.35% RSI (14)51.25 Recom1.00
Dividend Gr. 3/5Y-17.02% 4.24% Current Ratio1.77 EPS Q/Q-56.52% SMA20-2.21% Beta0.19 Target Price13.00
Payout8888.89% Debt/Eq0.18 Sales Q/Q9.23% SMA505.63% Rel Volume0.20 Prev Close8.56
Employees272 LT Debt/Eq0.01 EarningsJan 08 BMO SMA20013.23% Avg Volume25.65K Price8.87
IPOMar 27, 1992 Option/ShortNo / Yes EPS/Sales Surpr.-20.00% 5.47% Trades Volume5,253 Change3.62%
Date Action Analyst Rating Change Price Target Change
Aug-18-09Initiated Next Generation Buy $15
Jan-20-26 07:15AM
Jan-14-26 08:00AM
Jan-08-26 04:00PM
10:39AM
08:07AM
08:00AM Loading…
08:00AM
Dec-30-25 08:00AM
Nov-18-25 04:01PM
09:15AM
08:00AM
Nov-17-25 07:18AM
Nov-14-25 06:35PM
Nov-11-25 08:00AM
Nov-07-25 09:05AM
Nov-06-25 05:40PM
08:00AM Loading…
Nov-04-25 08:00AM
Oct-15-25 08:00AM
Jul-16-25 08:00AM
Jul-11-25 03:01AM
Jul-10-25 03:50PM
08:08AM
08:00AM
Jul-09-25 09:20AM
Jul-01-25 08:00AM
Apr-16-25 08:22AM
08:00AM
Apr-11-25 03:00AM
12:30AM
Apr-10-25 10:42AM
09:25AM
08:19AM Loading…
08:19AM
08:00AM
Apr-03-25 08:00AM
Jan-15-25 04:00PM
Jan-10-25 02:00AM
Jan-09-25 10:36PM
Jan-08-25 08:00PM
06:59PM
05:00PM
Jan-02-25 08:00AM
Nov-20-24 02:03AM
Nov-19-24 09:35AM
08:41AM
08:00AM
Nov-18-24 10:24PM
Nov-12-24 08:00AM
Oct-16-24 08:00AM
Jul-17-24 08:00AM
Jul-12-24 08:01AM
12:22AM
Jul-11-24 12:52PM
09:45AM
08:43AM
08:00AM
Jul-02-24 08:00AM
Jun-06-24 08:50AM
Jun-04-24 09:40AM
May-29-24 04:00PM
May-23-24 12:00PM
May-20-24 08:50AM
May-03-24 12:45PM
May-02-24 08:50AM
Apr-17-24 12:45PM
08:00AM
Apr-16-24 08:50AM
08:44AM
Apr-12-24 03:01AM
12:02AM
Apr-11-24 09:10AM
08:07AM
08:00AM
Apr-04-24 08:00AM
Mar-22-24 05:06AM
Mar-06-24 12:12AM
Jan-17-24 08:03AM
Jan-12-24 08:15AM
Jan-11-24 11:09PM
03:03PM
09:15AM
08:39AM
08:09AM
08:00AM
Jan-04-24 08:00AM
Nov-22-23 07:26AM
12:42AM
Nov-21-23 09:18AM
08:18AM
08:02AM
Nov-15-23 08:00AM
Oct-30-23 06:05PM
Oct-18-23 07:00AM
Aug-10-23 08:38AM
Jul-27-23 06:06AM
Jul-20-23 06:10AM
Jul-19-23 08:00AM
Jul-17-23 06:00AM
Jul-13-23 11:12PM
09:15AM
08:07AM
08:00AM
Northern Technologies International Corp. engages in the development and marketing of proprietary environmentally beneficial products and services. It operates through the Natur-Tec and Zerust segments. The Natur-Tec segment manufactures bio-degradable and bio-based plastics for industrial and consumer applications. The Zerust segment provides corrosion mitigation solutions and services to oil, gas, and chemical processing applications. The company was founded in 1970 and is headquartered in Circle Pines, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NIGON RICHARDDirectorJul 24 '25Option Exercise7.4312,00089,16049,935Jul 28 05:26 PM
von Falkenhausen KonstantinDirectorMay 06 '25Buy7.231,1007,95318,219May 06 04:37 PM
Calderon Nancy E.DirectorApr 25 '25Buy7.451,0007,4527,954Apr 28 05:33 PM
Last Close
Feb 12  •  04:00PM ET
104.87
Dollar change
+0.64
Percentage change
0.61
%
CELC Celcuity Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-3.67 Insider Own19.50% Shs Outstand43.27M Perf Week0.57%
Market Cap4.85B Forward P/E- EPS next Y-4.08 Insider Trans1.43% Shs Float37.25M Perf Month0.63%
Enterprise Value4.72B PEG- EPS next Q-1.04 Inst Own119.22% Short Float26.40% Perf Quarter32.47%
Income-162.72M P/S- EPS this Y-36.17% Inst Trans5.47% Short Ratio11.27 Perf Half Y100.25%
Sales0.00M P/B38.80 EPS next Y-5.90% ROA-43.45% Short Interest9.84M Perf YTD5.14%
Book/sh2.70 P/C10.67 EPS next 5Y30.96% ROE-122.04% 52W High120.32 -12.84% Perf Year745.04%
Cash/sh9.83 P/FCF- EPS past 3/5Y-8.60% -31.53% ROIC-37.22% 52W Low7.57 1284.42% Perf 3Y792.51%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility5.49% 6.14% Perf 5Y532.89%
Dividend TTM- EV/Sales- EPS Y/Y TTM-40.75% Oper. Margin- ATR (14)5.93 Perf 10Y-
Dividend Ex-Date- Quick Ratio12.26 Sales Y/Y TTM- Profit Margin- RSI (14)46.85 Recom1.18
Dividend Gr. 3/5Y- - Current Ratio12.26 EPS Q/Q-32.20% SMA20-3.57% Beta0.39 Target Price114.20
Payout- Debt/Eq2.74 Sales Q/Q- SMA50-0.39% Rel Volume0.47 Prev Close104.23
Employees87 LT Debt/Eq2.74 EarningsNov 12 AMC SMA20083.32% Avg Volume872.60K Price104.87
IPOSep 20, 2017 Option/ShortYes / Yes EPS/Sales Surpr.9.68% - Trades Volume413,387 Change0.61%
Date Action Analyst Rating Change Price Target Change
Dec-12-25Initiated Wells Fargo Overweight $126
Nov-18-25Initiated Wolfe Research Outperform $110
Nov-17-25Downgrade H.C. Wainwright Buy → Neutral
Sep-22-25Initiated Guggenheim Buy $110
Jul-01-25Resumed Stifel Buy $30
Jul-22-24Initiated Leerink Partners Outperform $29
Feb-22-24Initiated Stifel Buy $40
Dec-08-23Initiated H.C. Wainwright Buy $27
Oct-08-21Initiated Canaccord Genuity Buy $50
Sep-07-21Initiated Jefferies Buy $48
Feb-12-26 04:05PM
Feb-11-26 11:42PM
Feb-04-26 07:05AM
Feb-02-26 09:33AM
Jan-27-26 09:40AM
07:30AM Loading…
Jan-20-26 07:30AM
Jan-11-26 12:59AM
Jan-06-26 11:47AM
Dec-16-25 09:23AM
Dec-11-25 08:24PM
02:35PM
Dec-03-25 04:43PM
Nov-26-25 04:05PM
07:05AM
Nov-23-25 07:02AM
09:35AM Loading…
Nov-18-25 09:35AM
Nov-17-25 04:05PM
09:34AM
Nov-13-25 12:01AM
Nov-12-25 04:01PM
Nov-06-25 10:08AM
10:03AM
Nov-05-25 07:05AM
Nov-04-25 07:05AM
Nov-03-25 05:22AM
Oct-21-25 12:55PM
Oct-20-25 04:13PM
10:02AM
Oct-18-25 04:30AM
04:30AM
04:30AM Loading…
04:30AM
Oct-07-25 09:00AM
Sep-30-25 12:47PM
Sep-22-25 09:15AM
Sep-09-25 04:01PM
Aug-27-25 04:05PM
Aug-15-25 03:24AM
Aug-14-25 04:01PM
Aug-07-25 07:05AM
Jul-30-25 06:30AM
Jul-29-25 03:46PM
02:15PM
09:56AM
09:43AM
Jul-28-25 04:02PM
02:09PM
11:55AM
10:09AM
09:42AM
08:15AM
07:00AM
Jul-25-25 04:05PM
Jul-24-25 04:01PM
Jul-14-25 07:05AM
Jun-30-25 07:05AM
May-21-25 07:05AM
May-15-25 09:56AM
03:16AM
May-14-25 04:01PM
May-07-25 07:05AM
Apr-01-25 08:41AM
07:05AM
03:03AM
Mar-31-25 10:50PM
04:01PM
Mar-24-25 07:05AM
Feb-27-25 10:10AM
Feb-25-25 07:05AM
Dec-11-24 07:05AM
Nov-15-24 02:20AM
Nov-14-24 04:01PM
Nov-12-24 07:05AM
Nov-07-24 07:05AM
Oct-09-24 06:26PM
Oct-07-24 09:10PM
Sep-10-24 09:55AM
Aug-20-24 12:00PM
Aug-14-24 04:01PM
Aug-07-24 07:05AM
Jun-03-24 04:01PM
May-30-24 07:36AM
07:00AM
May-16-24 11:54AM
03:08AM
May-15-24 08:55PM
06:04PM
04:01PM
May-08-24 07:05AM
May-03-24 12:15PM
Apr-04-24 07:05AM
Apr-01-24 01:38PM
Mar-28-24 06:51AM
Mar-27-24 08:53PM
05:51PM
04:01PM
Mar-21-24 11:17AM
Mar-20-24 07:05AM
Mar-06-24 07:05AM
Feb-28-24 07:05AM
Feb-22-24 04:05PM
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dalvey DavidDirectorJan 27 '26Sale120.0320,0002,400,53890,000Jan 29 04:31 PM
Dalvey DavidDirectorJan 27 '26Proposed Sale120.0320,0002,400,538Jan 27 12:21 PM
Buller Richard EDirectorDec 05 '25Option Exercise5.503,00016,5009,760Dec 09 04:23 PM
Buller Richard EDirectorDec 05 '25Sale105.693,000317,0706,760Dec 09 04:23 PM
Furcht LeoDirectorDec 04 '25Option Exercise7.602501,90011,000Dec 08 04:30 PM
Buller Richard EDirectorDec 05 '25Proposed Sale105.683,000317,040Dec 05 05:31 PM
Buller Richard EDirectorDec 01 '25Option Exercise14.831,10016,3138,360Dec 03 04:09 PM
Buller Richard EDirectorDec 01 '25Sale98.131,100107,9487,260Dec 03 04:09 PM
Buller Richard EDirectorDec 01 '25Proposed Sale98.131,100107,943Dec 01 05:46 PM
Dalvey DavidDirectorNov 21 '25Sale100.0015,0001,500,016110,000Nov 24 04:07 PM
Buller Richard EDirectorNov 20 '25Option Exercise14.833,90057,83711,160Nov 21 04:14 PM
Buller Richard EDirectorNov 20 '25Sale96.733,900377,2557,260Nov 21 04:14 PM
Dalvey DavidDirectorNov 21 '25Proposed Sale100.0015,0001,500,016Nov 21 01:41 PM
Buller Richard EDirectorNov 20 '25Proposed Sale96.733,900377,255Nov 20 04:33 PM
BAKER BROS. ADVISORS LP10% OwnerSep 08 '25Buy56.27170,1009,571,3197,211,484Sep 10 04:06 PM
Dalvey DavidDirectorJul 28 '25Sale43.98100,0004,397,603125,000Jul 30 04:15 PM
Dalvey DavidDirectorJul 28 '25Sale45.129,325420,7670Jul 30 04:15 PM
Brightstone Venture Capital FuDirectorJul 28 '25Proposed Sale43.98100,0004,397,605Jul 28 02:52 PM
Dalvey DavidDirectorJul 28 '25Proposed Sale45.129,325420,766Jul 28 02:00 PM